These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 26418882)
1. Biomarkers of Brain Structure and Function for Neurodegenerative Disorders: Are They Adequate for Go/No Go Decisions in Drug Development? Potter WZ Clin Pharmacol Ther; 2015 Nov; 98(5):472-4. PubMed ID: 26418882 [TBL] [Abstract][Full Text] [Related]
2. The future of neurodegenerative diseases: emerging targets, treatments and technologies. Voss J; Ebert A; Wolfe M; Lindsley C; Cookson M; Deane R Future Med Chem; 2012 Sep; 4(13):1661-9. PubMed ID: 22924504 [No Abstract] [Full Text] [Related]
3. In vivo MR imaging of brain networks: illusion or revolution? Moser E; Ranjeva JP MAGMA; 2010 Dec; 23(5-6):275-7. PubMed ID: 21136136 [No Abstract] [Full Text] [Related]
4. Radioligands for brain imaging of the kappa-opioid system. Machulla HJ; Heinz A J Nucl Med; 2005 Mar; 46(3):386-7. PubMed ID: 15750146 [No Abstract] [Full Text] [Related]
5. High-field magnetic resonance imaging of brain iron: birth of a biomarker? Schenck JF; Zimmerman EA NMR Biomed; 2004 Nov; 17(7):433-45. PubMed ID: 15523705 [TBL] [Abstract][Full Text] [Related]
6. Role of iron in neurodegenerative disorders. Berg D; Youdim MB Top Magn Reson Imaging; 2006 Feb; 17(1):5-17. PubMed ID: 17179893 [TBL] [Abstract][Full Text] [Related]
7. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases. Danta CC; Piplani P Expert Opin Drug Discov; 2014 Oct; 9(10):1205-22. PubMed ID: 25056182 [TBL] [Abstract][Full Text] [Related]
8. Fluorinated molecules in the diagnosis and treatment of neurodegenerative diseases. Gaye B; Adejare A Future Med Chem; 2009 Aug; 1(5):821-33. PubMed ID: 21426082 [TBL] [Abstract][Full Text] [Related]
9. Skin biomarkers for neurodegenerative disease: a future perspective. Castanedo-Cazares JP; Rodriguez-Leyva I Neurodegener Dis Manag; 2015 Dec; 5(6):465-7. PubMed ID: 26619251 [No Abstract] [Full Text] [Related]
10. Current and emerging imaging in relation to drug discovery in airways disease. King GG Pulm Pharmacol Ther; 2011 Oct; 24(5):497-504. PubMed ID: 21807109 [TBL] [Abstract][Full Text] [Related]
11. Functional imaging in neurodegenerative disorders: past, present and future. Pagani M; Sonni I; Capriotti G Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):329-31. PubMed ID: 25519924 [No Abstract] [Full Text] [Related]
12. Unbiased approaches to biomarker discovery in neurodegenerative diseases. Chen-Plotkin AS Neuron; 2014 Nov; 84(3):594-607. PubMed ID: 25442938 [TBL] [Abstract][Full Text] [Related]
13. Location of the primary gustatory area in humans and its properties, studied by magnetoencephalography. Kobayakawa T; Wakita M; Saito S; Gotow N; Sakai N; Ogawa H Chem Senses; 2005 Jan; 30 Suppl 1():i226-7. PubMed ID: 15738127 [No Abstract] [Full Text] [Related]
14. New tools for the evaluation of patients with neurodegenerative diseases. Dickerson BC Neurodegener Dis Manag; 2014; 4(6):403-5. PubMed ID: 25531684 [No Abstract] [Full Text] [Related]
15. The role of clinical imaging in oncological drug development. Murphy PS; McCarthy TJ; Dzik-Jurasz AS Br J Radiol; 2008 Sep; 81(969):685-92. PubMed ID: 18541632 [TBL] [Abstract][Full Text] [Related]
16. [Role of functional neuroimaging in the surgical treatment of epilepsy]. Kawai K Brain Nerve; 2012 Sep; 64(9):1013-22. PubMed ID: 22941839 [TBL] [Abstract][Full Text] [Related]
18. Modeling neurodegenerative diseases using stem cells: is it accelerating drug discovery? Ebert AD Future Med Chem; 2012 Sep; 4(13):1651-3. PubMed ID: 22924501 [No Abstract] [Full Text] [Related]